Mestdag M, Degey S, Deflandre E. [Perioperative smoking cessation (conventional smoking and e-cigarettes) in 2023. A narrative review of the literature].
Rev Mal Respir 2024;
41:237-247. [PMID:
38429192 DOI:
10.1016/j.rmr.2024.02.001]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 12/19/2023] [Indexed: 03/03/2024]
Abstract
INTRODUCTION
Tobacco addiction is the leading cause of preventable death. During the perioperative period, patients who smoke are at increased risk of systemic as well as surgical site complications.
STATE OF THE ART
Surgery is an ideal time for change of lifestyle habits. It is vital to seize this opportunity to improve the patient's health in the long- as well as the short-term. Smoking cessation should be encouraged in all surgical patients. Initiating smoking cessation combines pharmacological treatment and a behavioral approach. In this field, significant advances have been recorded over the last decade. This review proposes a practical approach that every practitioner will be able to apply.
PERSPECTIVES
In this review, we will also examine ongoing research, particularly as regards vaccination and the place of biomarkers.
CONCLUSIONS
Smoking represents a major source of health-related complications. Smoking cessation must therefore remain a priority in the management of medical and surgical patients.
Collapse